VRS
AVIR icon

Virginia Retirement Systems’s Atea Pharmaceuticals AVIR Stock Holding History

Virginia Retirement Systems’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-42,200
Closed -$141K – 975
2023
Q1 		$141K Sell
42,200
-17,400
-29% -$70.6K ﹤0.01% 983
2022
Q4 		$287K Buy
59,600
+32,500
+120% +$164K ﹤0.01% 981
2022
Q3 		$154K Buy
+27,100
New +$207K ﹤0.01% 1084
2022
Q1 		$142K Buy
+19,600
New +$133K ﹤0.01% 1076

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virginia Retirement Systems's AVIR Position: Q2 2023 in Review

Virginia Retirement Systems sold out of Atea Pharmaceuticals (AVIR) in Q2 2023, closing a stake of 42,200 shares — an estimated $141K sold.

Virginia Retirement Systems first reported a position in AVIR in Q1 2022 and held it in 4 quarters. The position peaked at $287K in Q4 2022. 133 funds tracked by Wall St. Rank hold AVIR as of Q2 2023.

  • Virginia Retirement Systems reported no remaining Atea Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Virginia Retirement Systems sold 42,200 Atea Pharmaceuticals shares in Q2 2023, an estimated $141K.
  • Virginia Retirement Systems first reported a position in Atea Pharmaceuticals in Q1 2022 and held it in 4 quarters.
  • Virginia Retirement Systems's Atea Pharmaceuticals position peaked at $287K in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2023.

Based on Virginia Retirement Systems's 13F filing for Q2 2023, filed 22 Aug 2023.